By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sangamo BioSciences, Inc. 

501 Canal Boulevard, Suite A100

Richmond  California  94804  U.S.A.
Phone: 510-970-6000 Fax: 510-236-8951




Rosetta Inpharmatics, Inc.  Functional genomic studies on potential therapeutic targets

Company News
Sangamo BioSciences, Inc. (SGMO) Presents New Data At American Society of Hematology Meeting Demonstrating Broad Application Of ZFN Mediated Genome-Editing Approach To Therapeutics For Hemophilia And Lysosomal Storage Disorders 12/8/2014 9:18:38 AM
Sangamo BioSciences, Inc. (SGMO) Announces Presentation At The 26th Annual Piper Jaffray Healthcare Conference 11/19/2014 12:47:47 PM
Sangamo BioSciences, Inc. (SGMO) Presents Study At Society for Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms 11/19/2014 11:26:51 AM
Sangamo BioSciences, Inc. (SGMO) President And CEO Edward Lanphier To Serve As Chairman Of The Alliance for Regenerative Medicine (ARM) 11/10/2014 9:42:09 AM
Sangamo BioSciences, Inc. (SGMO) Reports Third Quarter 2014 Financial Results 10/23/2014 7:37:43 AM
Sangamo BioSciences, Inc. (SGMO) ZFP Therapeutic Program In HIV/AIDS Featured At Three Major Scientific Conferences In October 2014 10/16/2014 7:47:01 AM
Sangamo BioSciences, Inc. (SGMO) Announces Third Quarter 2014 Conference Call And Webcast 10/16/2014 7:23:10 AM
Sangamo BioSciences, Inc. (SGMO) Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases 9/10/2014 8:04:39 AM
Sangamo BioSciences, Inc. (SGMO) Announces Presentation At ICAAC Of New Clinical Data Demonstrating Sustained Functional Control Of Viremia In Multiple HIV-Infected Subjects Treated With SB-728-T 9/8/2014 8:09:16 AM
Sangamo BioSciences, Inc. (SGMO) Announces Presentation At The 2014 Morgan Stanley (MST) Global Healthcare Conference 9/3/2014 4:13:19 PM